Pharmacological Roadmap for Treatment Resistant Depression – Part 2

Published January 22, 2013

Pharmacological Roadmap for Treatment Resistant Depression – Part 2 – medicaidmentalhealth.org Srijan Sen, MD, Ph.D. — Assistant Professor of Psychiatry, University of Michigan

Alkermes Maintains Fiscal 2013 View – Analyst Blog

Filed under: treatment resistant depression

Interesting candidates include ALKS 9070/aripiprazole lauroxil (phase III: data expected by the end of calendar 2013) for treating schizophrenia, ALKS 5461 (a combination of ALKS 33 and buprenorphine) for treatment-resistant depression (phase II, data …
Read more on InvestorIdeas.com (press release)

Brainsway Deep TMS Transcranial Magnetic Stimulation System FDA Cleared to …

Filed under: treatment resistant depression

… Deep TMS Transcranial Magnetic Stimulation System FDA Cleared to Treat Depression Jerusalem, Israel based Brainsway finally won FDA clearance for its Deep TMS (transcranial magnetic stimulation) to be used for treatment of drug resistant depression.
Read more on Medgadget.com

Electric Stimulation of Brain Produces Opiate-Like Pain Relief

Filed under: treatment resistant depression

“I first used tDCS to treat fibromyalgia five years ago. Subsequently, I've used tDCS for migraine, complex regional pain syndrome, treatment-resistant depression, temporomandibular joint disorder (TMJ), chronic daily headaches, bipolar disorder and …
Read more on American News Report

Find More Treatment Resistant Depression Information…